To improve medical treatment, researchers test new drug ingredients on biological cells. By combining two microscopy techniques, the time required for testing can be reduced by 50 to 80 percent.
And far fewer measurements are needed.
When developing new medications, biologists and pharma- cologists test different active ingredients and chemical compounds. The main purpose is to find out how biological cells react to these substances. To do so, researchers often use a fluorescence microscope that produces digital, holo- graphic images, i.e. computer-generated holograms in which the cells being studied can be viewed in three dimen- sions. The hologram is first created as an optical image, which is then digitized for recording and analysis on the computer. The computer calculates the data needed to display the three-dimensional image of the cells. This method has several advantages. The researchers don’t have to use markers to make the cells visible. They can examine the cells without touching them. And the cells can be characterized in vivo – scientists refer to this as in vivo testing.
To obtain precise and reliable answers to the question of how the cells react to chemical substances, each cell must be placed in an individual, tiny hollow (well) on a microfluidic chip, i.e. one cell per well. This ensures that the cells are not influenced by the presence of other cells. Another requirement is that the cells must be of the same size, so that their reactions to the active agent can be compared. The problem is that it is difficult to transfer single cells to the tiny wells. Often, the researchers pour them in together with the nutrient solution in which they were grown. This can have two unwanted consequences: firstly that several cells occupy the same well and secondly that the cells are of all different sizes. It can even happen that cells swim out of the wells during the test. The researchers have to take all these factors into account by employing statistical averaging. In other words they have to carry out innumerable measurements and test large numbers of cells in order to obtain a scientifically accurate result – an undertaking that can be extremely tedious and time-consuming.
Combination of digital holographic microscopy and optical tweezers
Researchers at the Fraunhofer Institute for Production Technology IPT in Aachen have found a solution to this problem. “It combines digital holographic microscopy with the use of optical tweezers,” reveals IPT group manager Stephan Stürwald. Optical tweezers are a special instrument that uses the force of a focused laser beam to trap and move micro- scopic objects. This tool enables the researchers to pick up selected cells, transfer them to individual wells of a microarray, and keep them trapped there. “By combining these two instruments, we can save between 50 and 80 percent of the time normally needed for such work, depending on the type of cell and the test method employed. That’s mainly because we don’t have to carry out so many repeated measurements,” explains Stürwald. The system is very easy to use, and the optical tweezers can also be controlled via the touchscreen of a tablet PC.
The combination of these two techniques not only simplifies current test procedures but also allows new tests to be developed. For instance, it is possible to position cells at a defined distance from one another, thus creating different patterns. In this way, the scien- tists will be able to observe cell interactions, because the spacing between them is ident- ical and fixed. One possible application is in the study of apoptosis, or sudden cell death. When a cell dies by apoptosis, it excretes substances that affect the behavior of other cells around it. But within what radius? Researchers will now be able to directly answer this question. The new system will also enable them to use the laser to selectively destroy cells that that are unsuitable for testing. A prototype of the system has already been built. It con- sists of two modules: the optical tweezers and the digital holographic microscope. The researchers have successfully carried out initial tests using the new system.
The Latest on: Testing of new pharmaceuticals
[google_news title=”” keyword=”Testing of new pharmaceuticals” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Testing of new pharmaceuticals
- Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2024 Earnings Call Transcripton May 9, 2024 at 9:37 am
May 8, 2024 Vanda Pharmaceuticals Inc. isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing by. My name is ...
- Crinetics Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Updateon May 9, 2024 at 9:05 am
whether as a result of any new information, future events, changed circumstances or otherwise. Crinetics Pharmaceuticals NewsMORE Related Stocks ...
- Rhythm Pharmaceuticals Announces New Employment Inducement Grantson May 9, 2024 at 9:01 am
covering an aggregate of 15,150 shares of its common stock to seven new employees. These inducement RSUs are subject to the terms of the Rhythm Pharmaceuticals, Inc. 2022 Employment Inducement Plan ...
- UB’s new mass spectrometer can accelerate discoveries of new drug targets and biomarkerson May 5, 2024 at 5:00 pm
professor in UB’s Department of Pharmaceutical Sciences who serves ... and potential therapeutic targets.” Their initial test, conducted in December 2023, indicated that with this new technology, they ...
- Global Pharmaceutical Dissolution Testing Services Industryon April 26, 2024 at 6:22 am
Global Pharmaceutical Dissolution Testing Services Industry value of US$ 693.12 Million in 2023, by registering a CAGR of 8.3% By 2033 ...
- Rhythm Pharmaceuticals Announces New Employment Inducement Grantson April 16, 2024 at 1:01 pm
BOSTON, April 16, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals ... an aggregate of 31,220 shares of its common stock to eight new employees, consisting of inducement stock options to purchase ...
- Marinus Pharmaceuticals loses 80% of its market value in one day after setback for new drug candidateon April 14, 2024 at 5:00 pm
Marinus Pharmaceuticals of Radnor said an independent data monitoring committee has recommended the company continue late-stage testing of its new drug candidate targeting refractory status ...
- Pharmaceutical Analytical Testing Outsourcing Market Report By Types, Applications, Players And Regions, Share, Cagr ,Outlook 2033on April 10, 2024 at 5:00 pm
The continuous expansion of the pharmaceutical industry globally creates a burgeoning demand for analytical testing services. With an increasing number of new drugs entering the market, pharmaceutical ...
- New microbiology lab will boost pharmaceutical production- Rutoon November 22, 2023 at 3:33 am
President William Ruto has launched a new ... testing. It will also serve as a training and research facility for students and professionals in the field of microbiology and pharmaceutical sciences.
- Medicinal Chemistry/Pharmaceuticalson May 26, 2021 at 1:05 pm
including formulating drugs used to treat patients with diseases Testing potential new bio-active compounds in patient populations Developing guidelines for how new pharmaceuticals will be used Many ...
via Bing News